# Advanced Animal Diagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/advanced-animal-diagnostics

- Industry: Medical Devices & Equipment
- Headquarters: Morrisville, US
- Website: www.advancedanimaldiagnostics.com
- Total disclosed funding: $32M
- Latest round: Series C (Nov 18, 2014)
- Investors on record: 6

## About

Advanced Animal Diagnostics develops innovative diagnostic solutions for the livestock industry, emphasizing rapid, on-farm testing to enhance animal health management for producers.Founded in 2001 in Morrisville, US, Advanced Animal Diagnostics specializes in diagnostic solutions for animal health. The company has undergone strategic pivots to focus on rapid, on-farm diagnostics. Joy Drach serves as the CEO. In May 2021, the company raised USD 7.000 mn in a funding round led by Mountain Group Partners, with participation from several investors, including Alexandria Venture Investments and LabCorp Ventures. The total amount raised by the company is USD 7.000 mn.AAD specializes in advanced diagnostic solutions for the livestock industry, focusing primarily on rapid, on-farm diagnostics that aid producers in managing animal health. The company’s core offerings include the QScout® BLD and QScout® MLD tests, which enable beef and dairy producers to detect diseases early and make informed treatment decisions. The QScout® BLD test assists beef producers in determining the appropriate use of antibiotics, thereby preventing losses and maximizing profitability. Similarly, the QScout® MLD test identifies subclinical mastitis infections in dairy cattle before any significant losses occur. AAD’s customer base primarily consists of livestock producers across North America, Europe, and select regions in Asia, all of which face the challenges of maintaining animal health while meeting the increasing global demand for high-quality protein.Revenue generation for AAD is primarily derived from the sale of its diagnostic products to livestock producers, facilitated through direct B2B transactions. Clients typically procure the QScout® diagnostic tests, which are utilized onsite to provide immediate results, aiding in timely decision-making. The transaction structure often involves bulk purchases, with producers opting for extended service agreements or subscription-based models for continuous supply and support. Pricing plans are aligned with the scale of the operation and specific product needs, ensuring accessibility for both small and large-scale producers. This transactional framework strengthens AAD's commitment to improving animal care while maintaining a financially sustainable model for its clients.In May 2021, Advanced Animal Diagnostics raised USD 7.000 mn in venture funding to expand the commercial use of its animal tests and submit 510(k) applications for its human blood tests to the FDA. The company plans to introduce new diagnostic products tailored to meet the evolving needs of livestock producers while expanding its market reach into new geographic regions, including additional areas in Europe and Asia by 2023. The recent funding will play a crucial role in supporting these initiatives, enhancing both product development and market expansion efforts.

## Funding rounds

- Series C, Nov 18, 2014, $15M — Intersouth Partners, Novartis Venture Fund, Cultivian Sandbox Ventures, Laboratory Corporation of America Holdings, Kansas Bioscience Authority, Middleland Capital
- Series B, Apr 10, 2013, $12M — Intersouth Partners, Novartis Venture Fund
- Series B, Mar 10, 2011, $5.7M — Intersouth Partners, Novartis Venture Fund

## Investors

- Intersouth Partners (https://capitalatlas.ai/funds/intersouth-partners) — Series B, Series C
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series B, Series C
- Cultivian Sandbox Ventures (https://capitalatlas.ai/funds/cultivian-sandbox-ventures) — Series C
- Laboratory Corporation of America Holdings — Series C
- Kansas Bioscience Authority — Series C
- Middleland Capital — Series C